|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Microfluidizer Á¾ÇÕÄ«´Ù·Î±× |
Phone |
|
|
  ´ëÇ¥ÀüÈ |
1577-7956   |
  º»     »ç |
031-457-9187   |
  ´ë     Àü |
042-932-1265 |
|
|
Web Site Visitors |
|
|
  Today |
76     |
  Yesterday |
619     |
  Since 2006 |
1,948,492     |
|
|
|
|
¿µÁøÄÚÆÛ·¹ÀÌ¼Ç Á¾ÇÕÄ«´Ù·Î±× |
|
|
|
|
|
Before being acquired by GlaxoSmithKline, biotechnology company Corixa (Seattle, WA) developed and produced an oil-water emulsion to be used as a vaccine adjuvant. |
|
| ¿øº»º¸±â | ¸®½ºÆ®µ¹¾Æ°¡±â | |
Introduction
»ý¸í°øÇÐ ±â¾÷ÀÎ Corixa ´Â water-in-oil emulsion À» ±â¹ÝÀ¸·Î ÇÏ´Â Vaccine Adjuvant ¸¦ °³¹ß »ý»êÇϴ ȸ»ç·Î¼
Microfluidizer High Shear Processor ¸¦ ÀÌ¿ëÇÏ¿© nanoemulsion type Vaccine Adjuvant ¸¦ ¼º°øÀûÀ¸·Î °³¹ßÇÏ¿´´Ù. |
|
|
Corixa ´Â ±âÁ¸ ÀÏ¹Ý High Pressure Homogenizer ¸¦ »ç¿ëÇÏ¿´À» ¶§ ÀÔµµ°¡ ±ÕÀÏÇÏÁö ¾Ê¾Ò°í »çÀÌÁî°¡ 200nm ÀÌ»óÀÎ
emulsion ÀÔÀÚ°¡ ¸¹¾Æ ¾î·Á¿òÀ» °Þ°í ÀÖ¾ú´Ù. Microfluidics ¿ÍÀÇ ¹ÌÆÃÀ» °ÅÄ£ ÈÄ Corixa »ç´Â Microfluidizer ÀåºñÀÇ
fixed-geometry interaction chamber ¸¦ »ç¿ëÇϸé ÀÔµµºÐÆ÷°¡ ±ÕÀÏÇÏ°í emulsion ÀÔÀÚ »çÀÌÁî´Â
ÈξÀ ÀÛÀº °á°ú¸¦ ±¸ÇÒ ¼ö ÀÖ´Ù´Â °ÍÀ» ¾Ë°Ô µÇ¾ú´Ù.
Corixa ´Â Microfluidizer °í¾ÐºÐ»êÀåºñ¿Í ´Ù¸¥ ÀÏ¹Ý °í¾Ð±ÕÁú±âÀÇ ¼º´ÉÀ» ºñ±³ÇÏ´Â ½ÇÇèÀ» ÇÏ¿´´Ù.
OBJECTIVES
Corixa ´Â Microfluidizer Processor ¿Í ´Ù¸¥ High Pressure Homogenizer Áß ¾î´À °ÍÀÌ emulsion ó¸® °øÁ¤¿¡
°¡Àå ÀûÀýÇÑ Áö¸¦ ºñ±³Çϱâ À§ÇØ ´ÙÀ½°ú °°Àº ³»¿ëÀ» ÆÇ´ÜÀÇ ±âÁØÀ¸·Î Çϱâ·Î ÇÏ¿´´Ù.
Average particle size (Æò±Õ ÀÔµµºÐÆ÷)
Polydispersity (ÀÔÀÚ ±ÕÀϼº)
Active concentration post-filtration
METHODS
3 batch ÀÇ pre-emulsion material À» ÁغñÇÏ¿© °¢°¢ ¹ÝÀ¸·Î ³ª´©¾î °¢ Àåºñ·Î Å×½ºÆ® ÇÏ¿´´Ù.
High Pressure Homogenization ÇÑ ÈÄ sterile filtration ÇÑ ÈÄ laser diffraction, fluorescence detector ¸¦
»ç¿ëÇÏ´Â HPLC ±×¸®°í gradual pore plugging model ½ÇÇèÀ» ÇÏ¿´´Ù.
RESULTS
Microfluidizer Processor °¡ ¸ðµç Å×½ºÆ® Ç׸ñ¿¡¼ ¿ùµîÈ÷ ÁÁÀº °á°ú¸¦ º¸¿© ÁÖ¾ú´Ù.
Comparison of Critical Quality Attributes
Analysis conducted on average of three batches processed by each technology
What this data shows
1. |
À§ Å×ÀÌºí¿¡¼ Leading Homogenizer ´Â ÀÏ¹Ý Valve ¹æ½ÄÀÇ High Pressure Homogenizer (ÀÌÇÏ HPH) ¸¦ ÀǹÌÇÕ´Ï´Ù. |
|
2. |
Corixa »ç´Â 150nm »çÀÌÁî ÀÌÇÏÀÇ water-in-oil emulsion À» ±¸ÇÏ´Â ¸ñÇ¥¿´´Ù. Microfluidizer °¡ 3 pass ¸¦ ÅëÇØ 141nm »çÀÌÁîÀÇ Æò±Õ ÀÔµµºÐÆ÷¸¦ °¡Áø °á°ú¸¦
±¸ÇÒ ¼ö ÀÖ¾úÀ¸³ª HPH ´Â 15 pass ¸¦ ÇÏ¿©µµ 185nm ÀÔµµ¸¦ °¡Áø °á°ú°¡ ³ª¿Ô´Ù. |
|
3. |
emulsion vaccine adjuvant ÀÇ Ç°Áú°ü¸®¸¦ À§ÇØ 200nm ÀÌ»óÀÇÀÔÀÚ´Â 10% À̳»·Î Á¸ÀçÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ¿´´Ù.
Microfluidizer ¸¦ ÀÌ¿ëÇÏ¿© ó¸®ÇÑ °á°ú 200nm ÀÌ»óÀÇ ÀÔÀÚ´Â ´Ü 0.51% °¡ Á¸Àç ÇßÁö¸¸ HPH ´Â 43.1% °¡ 200nm ÀÌ»óÀÇ ÀÔÀÚ°¡ Á¸ÀçÇß´Ù. |
|
4. |
filteration À» ÇÑ ÈÄ emulsion vaccine adjuvant ÇÒ¼ºµµ´Â ÀÌÀü°ú ºñÇØ 2% loss °¡ µÇ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ¿´´Ù. Microfluidizer ÀÇ °æ¿ì ´Ü 1% ÀÇ loss °¡ ¹ß»ýÇßÀ¸³ª
HPH ´Â 15% ÀÇ loss °¡ ¹ß»ýÇß´Ù. |
|
5. |
Microlfuidizer ¸¦ ÀÌ¿ëÇÑ emulsion vaccine adjuvant ÀÇ °æ¿ì filter ¸¦ Çϴµ¥ Liter ´ç 17cm©÷ °¡ ÇÊ¿äÇÏ¿´À¸³ª HPH ÀÇ °æ¿ì Liter ´ç 640cm©÷ °¡ ÇÊ¿äÇÏ¿´´Ù. |
Average Particle Size and Polydispersity
As a function of homogenization method, operating pressure = 25,000psi (1720bar)
What this data shows
emulsion vaccine adjuvant ÀÇ »ý»êÀ» °¢°¢ 3¹ø¾¿ ÇÑ ´ÙÀ½ Microfluidizer ¿Í HPH ÀÇ Æò±Õ ÀÔµµºÐÆ÷¸¦ ºÐ¼®ÇÏ¿´´Ù.
Microfluidizer ¿¡ ÀÇÇÑ emulsion ÀÇ Æò±Õ ÀÔµµºÐÆ÷´Â ÀÏ¹Ý HPH ¿¡ ºñÇØ Æò±Õ 50% °¡ ´õ ÀÛ¾ÒÀ¸¸ç ¶ÇÇÑ
batch »çÀÌÀÇ ÀÔÀÚ »çÀÌÁî ÆíÂ÷´Â ¸Å¿ì ÀÛ¾Ò´Ù.
Active Concentration Post-filtration
Recovery of active after filtration, averaged across three batches
What this data shows
Microfluidizer ÀÇ fixed-geometry interaction chamber ¿Í uniform processing conditions Ư¼º¿¡ ÀÇÇØ
batch °£ ÀçÇö¼ºÀÌ Å¹¿ùÇÏ°í ÀÔµµºÐÆ÷°¡ ¸Å¿ì ±ÕÀÏÇÏ¿´´Ù. ¹Ý¸é¿¡ ´Ù¸¥ High Pressure Homogenizer ÀÇ °æ¿ì
ÀÔµµºÐÆ÷°¡ ¸Å¿ì ºÒ±ÕÀÏÇÏ°í emulsion ÀÇ »çÀÌÁî°¡ ¸Å¿ì Ä¿ sample ÀÇ loss °¡ ½ÉÇÏ¿´´Ù.
CONCLUSIONS
Á¦Ç°ÀÇ Ç°Áú°ú °øÁ¤ÀÇ È¿À²¼ºÀÌ °³¼±µÇ´Â ÀÌ·¯ÇÑ Å×½ºÆ® °á°ú¸¦ ¹ÙÅÁÀ¸·Î Corixa ´Â ±âÁ¸ÀÇ Valve ¹æ½Ä High Pressure Homogenizer Æó±âÇÏ°í Microfluidizer °í¾ÐºÐ»êÀåºñ¸¦ ¼±ÅÃÇÏ¿© Á¦Ç°À» »ý»êÇÏ¿´´Ù.
|
|
|
|